Anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Author:

Solomon Sharon D1,Lindsley Kristina2,Vedula Satyanarayana S3,Krzystolik Magdalena G4,Hawkins Barbara S1

Affiliation:

1. Johns Hopkins University School of Medicine; Wilmer Eye Institute; 600 North Wolfe Street Maumenee 740 Baltimore Maryland USA 21287

2. Johns Hopkins Bloomberg School of Public Health; Department of Epidemiology; 615 North Wolfe Street, Mail Room E6132 Baltimore Maryland USA 21205

3. Johns Hopkins University; 3400 N. Charles Street Baltimore Maryland USA 21218

4. Mass Eye and Ear Infirmary; Department of Ophthalmology, Retina Service; 1 Randall Square, Suite 203 Providence Rhode Island USA 02904

Publisher

Wiley

Subject

Pharmacology (medical)

Reference308 articles.

1. Assessment of differential pharmacodynamic effects using optical coherence tomography in neovascular age-related macular degeneration;Keane;Investigative Ophthalmology and Visual Science,2012

2. Contrast sensitivity outcomes in the ABC Trial: a randomized trial of bevacizumab for neovascular age-related macular degeneration;Patel;Investigative Ophthalmology and Visual Science,2011

3. The ABC trial - a randomized double-masked phase III study of the efficacy and safety of Avastin® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularization secondary to age-related macular degeneration (AMD);Patel;Investigative Ophthalmology and Visual Science,2007

4. Impact of anti-vascular endothelial growth factor therapy on reading performance in age-related macular degeneration: a randomized controlled trial;Patel;Investigative Ophthalmology and Visual Science,2015

5. A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design;Patel;Trials,2008

Cited by 179 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3